Registro español de intervencionismo en cardiopatías congénitas.Primer informe oficial de la ACI-SEC y el GTH-SECPCC (2020)

  1. Fernando Ballesteros Tejerizo 1
  2. J.F. Coserria Sánchez 2
  3. Rafael Romaguera Torres 3
  4. C. Abelleira Pardeiro 4
  5. Ignacio Amat Santos 5
  6. Pedro Betrian Blasco 6
  7. Roberto Blanco Mata 7
  8. M.J. del Cerro Marín 8
  9. Alfredo Gómez Jaume 9
  10. Marta Flores Fernández 10
  11. Beatriz Insa Albert 11
  12. L. Jiménez Montañés 12
  13. Miguel José Navalón Pérez 13
  14. Soledad Ojeda 14
  15. Fernando Rueda Núñez 15
  16. Joaquín Sánchez Gila 16
  17. Ricardo Sanz Ruiz 17
  18. I. Zabala Arguelles 18
  1. 1 Servicio de Cardiología Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid, España
  2. 2 Servicio de Cardiología Pediátrica, Hospital Universitario Virgen del Rocío, Sevilla, España
  3. 3 Servicio de Cardiología, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, España
  4. 4 Servicio de Cardiología Infantil, Hospital Universitario La Paz, Madrid, España
  5. 5 Departamento de Cardiología, Hospital Clínico Universitario de Valladolid, Valladolid, España
  6. 6 Servicio de Cardiología Pediátrica, Hemodinámica Pediátrica, Hospital Universitari Vall d’Hebron, Barcelona, España
  7. 7 Sección de Hemodinámica-Cardiología, Hospital Universitario de Cruces, Barakaldo, Bilbao, España
  8. 8 Servicio de Cardiología Pediátrica y Unidad de Cardiopatías Congénitas, Hospital Universitario Ramón y Cajal, Madrid, España
  9. 9 Sección de Hemodinámica-Cardiología, Hospital Universitario Son Espases, Palma de Mallorca, España
  10. 10 Instituto Pediátrico del Corazón, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, España
  11. 11 Sección de Cardiología Infantil, Hospital Universitario y Politécnico La Fe, Valencia, España
  12. 12 Sección de Cardiología Infantil, Hospital Miguel Servet, Zaragoza, España
  13. 13 Sección de Cardiología Pediátrica, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, España
  14. 14 Servicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica (IMIBIC), Universidad de Córdoba, Córdoba, España
  15. 15 Unidad de Cardiopatías Congénitas, Servicio de Pediatría, Complejo Hospitalario Universitario de A Coruña, A Coruña, España
  16. 16 Servicio de Cardiología, Hospital Universitario Virgen de las Nieves de Granada, Granada, España
  17. 17 Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense de Madrid, Madrid, España
  18. 18 Sección de Cardiología Pediátrica, Hospital Regional Universitario de Málaga, Málaga, España
Mostrar afiliacións +
Revista:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Ano de publicación: 2022

Volume: 4

Número: 3

Páxinas: 173-180

Tipo: Artigo

DOI: 10.24875/RECIC.M21000257 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Outras publicacións en: REC: Interventional Cardiology

Resumo

Introduction and objectives: The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) and the Spanish Society of Pediatric Cardiology Working Group on Interventional Cardiology (GTH-SECPCC) introduce their annual activity report for 2020, the starting year of the pandemic of coronavirus disease (COVID-19). Methods: All Spanish centers with cath labs and interventional activity in congenital heart diseases were invited to participate. Data were collected online, and analyzed by an external company together with members from the ACI-SEC and the GTH-SECPCC. Results: A total of 16 centers participated (all of them public) including 30 cath labs experienced in the management of congenital heart diseases, 7 of them (23.3%) dedicated exclusively to pediatric patients. A total of 1046 diagnostic studies, and 1468 interventional cardiac catheterizations were registered. The interventional procedures were considered successful in 93.4% of the cases with rates of major procedural complications and mortality of 2%, and 0.1%, respectively. The most frequent procedures were atrial septal defect closure (377 cases), pulmonary angioplasty (244 cases), and the percutaneous closure of the patent ductus arteriosus (199 cases). Conclusions: This report is the first publication from the Spanish Cardiac Catheterization in Congenital Heart Diseases Registry. The data recorded are conditioned by the COVID-19 pandemic. Diagnostic cardiac catheterization still plays a key role in this field. Most interventional techniques have reported excellent security and efficacy rates.

Referencias bibliográficas

  • 1. Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología. Registro de Actividad ACI-SEC. 2020. Disponible en: http://www.registroactividadacisec.es. Consultado 21 Jun 2021.
  • 2. Romaguera R, Cruz-Gonzalez I, Jurado-Roman A, et al. Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak. Consensus statement of the Interventional Cardiology Association and the Ischemic Heart Disease and Acute Cardiac Care Association of the Spanish Society of Cardiology. REC Interv Cardiol. 2020;2:112-117.
  • 3. Moreno R, Diez JL, Diarte JA, et al. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak. Catheter Cardiovasc Interv. 2021;97:927-937.
  • 4. Romaguera R, Ojeda S, Cruz-González I, et al. Registro Español de Hemodinámica y Cardiología Intervencionista. XXX Informe Oficial de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2020) en el año de la pandemia de la COVID-19. Rev Esp Cardiol. 2021;74(12):1095-1105.
  • 5. Galindo A, Gómez-Montes E, Gómez O,et al.Fetal Aortic Valvuloplasty:Experience and Results of Two Tertiary Centers in Spain. Fetal Diagn Ther. 2017;42:262-270.
  • 6. Jayaram N, Spertus JA, Kennedy KF, et al. Modeling major adverse outcomes of pediatric and adult patients with congenital heart disease undergoing cardiac catheterization:Observations from the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment). Circulation. 2017;136:2009-2019.
  • 7. Hill KD, Du W, Fleming GA, et al. Validation and refinement of the catheterization RISk score for pediatrics (CRISP score):An analysis from the congenital cardiac interventional study consortium. Catheter Cardiovasc Interv. 2019;93:97-104.
  • 8. Taggart NW, Du W, Forbes TJ, et al. A Model for Assessment of Catheterization Risk in Adults With Congenital Heart Disease. Am J Cardiol. 2019;123:1527-1531.
  • 9. Solana-Gracia R, Mendoza Soto A, Carrasco Moreno JI, et al. Registro español de cierre percutáneo de comunicación interventricular con dispositivo NitOcclud LêVSD-Coil. Experiencia tras más de 100 implantes. Rev Esp Cardiol. 2021;74:591-601.
  • 10. Saung MT, McCracken C, Sachdeva R, Petit CJ. Outcomes Following Balloon Aortic Valvuloplasty Versus Surgical Valvotomy in Congenital Aortic Valve Stenosis:A Meta-Analysis. J Invasive Cardiol. 2019;31:E133-E142.
  • 11. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-1032.
  • 12. Turc G, Calvet D, Guerin P, et al. Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale:systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study. J Am Heart Assoc. 2018;7:e008356.
  • 13. Rodríguez Ogando A, Planelles Asensio I, de la Blanca ARS, et al. Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants:Which are the Real Benefits of the Percutaneous Approach?Pediatr Cardiol. 2018;39:398-410.
  • 14. Shyam K. Sathanandam, Dan Gutfinger, et al. Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheter Cardiovasc Inerv. 2020;96:1266-1276.
  • 15. Stotut KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease:executive summary:a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139:e637-697.
  • 16. Kim GB, Song MK, Bae EJ, et al. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11:e006494.
Fonte de datos: Dialnet